Sat 3/28/2020 23:48 ET
DJIA21636.78878.454.06%TELCO159.703.312.07%GOLD1630.6020.551.26%Shanghai2772.207.210.26%
S&P 5002541.4785.653.37%BANKS314.0414.454.60%OIL21.840.763.48%BITCOIN6160.91258.144.19%
NASDAQ7502.38284.343.79%PHARM520.9210.472.01%US/EU1.110.000.01%Futures2519.1288.923.53%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - YM BioSciences - YMI   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  
From: crainiac (Rep: 4173)Date: 12/07/2012 12:27
Forum: YM BioSciences - Msg #3437Thread #673482622 (Rec: 0)
in here on the dip, two presentations at ASH 2012 on Sunday, links below:

Phase I/II Study of CYT387, a JAK1/JAK2 Inhibitor for the Treatment of Myelofibrosis

https://ash.confex.com/ash/2012/webprogram/Paper51560.html

Gene Expression Profiling within the Context of JAK Inhibitor Therapy for Myelofibrosis: Correlation with Treatment Effect and Anemia Response

https://ash.confex.com/ash/2012/webprogram/Paper51276.html

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser crainiac: Reward | Watch | IgnoreYMI: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.